Putting neoplasia risks attributed to immunomodulators and biologics into perspective and what to do if a malignancy develops

08/01/2018

Related Content

Influenza
Influenza
Nasal Spray Flu Vaccine Now Labeled Inadequate by CDC
03/07/2017
Michael Banks, MD, discusses the results of a 2016 study that suggested that nasal spray might not be an effective vaccination tool.
03/07/2017
Diabetes
John E. Anderson, MD
Diabetes
CRS 2014: What Do I Prescribe After Metformin?
10/11/2014
John E. Anderson, MD, discusses the details from his live presentation at the 2014 Summit on Metformin, and what physicians can prescribe following this treatment, with Co-Chair Edward Shahady, MD, FAAFP,...
10/11/2014
Endocrinology
Endocrinology
The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and CVD: An Analysis of the COMPASS Trial
07/02/2020
In this video, Deepak Bhatt, MD, MPH, highlights the findings from an analysis of the COMPASS trial that included patients with diabetes.
07/02/2020
Inflammatory Bowel Disease
Dr Bruce Sands
Inflammatory Bowel Disease
Dr Bruce Sands on the Future of JAK Inhibitors for IBD
03/04/2019
In this video, Dr Bruce Sands discusses the role of current and future JAK inhibitors for the treatment of inflammatory bowel disease.
03/04/2019
Treatment
Treatment
Strategic Target Adjustment Revamps Antibiotic Development
12/21/2016
Edmond J. LaVoie, PhD, discusses a new antibiotic that specifically targets variants of the MRSA bacteria, and should be able to circumvent the problem of antibiotic resistance in certain bacterial...
12/21/2016